Gene · 79188
TMEM43: transmembrane protein 43
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TMEM43: transmembrane protein 43. Genes, record 79188. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/79188
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9BTV4 | Transmembrane protein 43 | 400 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents139
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 67845 | Q9BTV4 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4247 | Q9BTV4 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 4909 | Q9BTV4 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 4909 | Q9BTV4 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4247 | Q9BTV4 | Espacenet |
| EP 4493703 A2 | 2025-01-22 | 14 | Q9BTV4 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 91755 | Q9BTV4 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 5026 | Q9BTV4 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 194726 | Q9BTV4 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 11728 | Q9BTV4 | Espacenet |
1 to 10 of 139
See all 139 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,122
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TMEM43 papers | Newest fiscal year |
|---|---|---|---|
| P50CA058223 | SPORE in Breast Cancer | 30 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 19 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 15 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 14 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 8 | 2025 |
| R01CA148761 | Therapeutic Targeting of Breast Cancer Tumor Initiating Cells | 8 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 6 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 5 | 2025 |
| P30CA012197 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 1,122Source NIH's project files
See all 1,122 nih grantsPapers1,602
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a nuclear transcriptional module associated with ERα and E2F/FOXM1 signaling across PAM50 breast cancer subtypes. | Front Oncol | 2026 | 42620280 | PubTator, text mining | PubMed |
| Gene Therapy for Cardiovascular and Cerebrovascular Disease: Mechanisms, Translational Barriers, and the Road Ahead. | Biomedicines | 2026 | 42193469 | PubTator, text mining | PubMed |
| Explainable machine learning-guided integrated multiomics analysis reveals macrophage-driven immune suppression in breast cancer. | Nat Commun | 2026 | 42185288 | PubTator, text mining | PubMed |
| Spatial transcriptional mapping reveals the molecular characteristics of juxtaglomerular cell tumors. | Front Oncol | 2026 | 42038360 | PubTator, text mining | PubMed |
| Newfoundland Mutation TMEM43-p.S358L Causes Impaired Cardiac Energy Metabolism and Mitochondrial Function Through Altered Protein Interaction. | Circ Genom Precis Med | 2026 | 41919408 | PubTator, text mining | PubMed |
| Characterization, immune cell phenotyping and differential gene expression analysis of brain metastases and primary breast cancer samples. | Sci Rep | 2026 | 41905976 | PubTator, text mining | PubMed |
| CXCL12-mediated T cell infiltration drives breast cancer metastasis. | Clin Exp Med | 2026 | 41902967 | PubTator, text mining | PubMed |
| An explainable-AI framework reveals novel lncRNAs specific for breast cancer subtypes. | Front Bioinform | 2026 | 41884707 | PubTator, text mining | PubMed |
| Over-the-Counter Loperamide Overdose Resulting in Cardiac Arrest. | JACC Case Rep | 2026 | 41854325 | PubTator, text mining | PubMed |
| An integrative analysis reveals the mechanism of plastic stabilizers inducing breast cancer. | PLoS Comput Biol | 2026 | 41790613 | PubTator, text mining | PubMed |
1 to 10 of 1,602
See all 1,602 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/79188
GET https://conductscience.org/api/genes/v1/79188/patents?page=2